Pierre Régibeau

Chief Economist

Pierre Régibeau was formely Chief Economist of DG Competition (2019 - 2023). Dr. Régibeau received a BSc in Economics from the University of Liège (Belgium) and a Ph.D. in Economics from the University of California at Berkeley. After graduation, he embarked on an academic career at institutions such as the Massachussetts Institute of Technology, Kellogg School of management (Northwestern University), the Institute for Economic Analysis (Barcelona) and the University of Essex, where he currently is Honorary Visiting Professor. He has published academic and policy papers in leading reviews. His areas of specialty include industrial organisation, with a special emphasis on technology-intensive industry and intellectual property rights and International Trade. He was on the Board of Editors of the Journal of Industrial Economics for more than ten years. He has also been teaching about the interface between IPRs and Competition Policy for the last 14 years in the well-established CRESSE summer school attended by lawyers and personnel from competition and regulatory authorities. Dr. Régibeau has also been a member of the EAGCP (Economic Advising Group on Competition Policy) at the EU Commission. In parallel to his academic career, Dr. Régibeau has been active in economic consulting. He has been involved in numerous cases covering a wide variety of topics and sectors of activity. These involve cases in front of the European Commission but also in front of the national authorities from the UK, France, Portugal, Germany, the Netherland, Finland, Russia, South Africa, South Korea, Australia, China and the USA.


16375 | Évènements


US antitrust takes big steps : How to read that in Europe ?
Pierre Régibeau 28 octobre 2020 Webinar
Pierre Régibeau (DG COMP)
Pierre Régibeau 19 février 2020 London


6829 Revue

Pierre Régibeau, Oliver Latham Pierre Régibeau (DG COMP) : The exit interview


Interview conducted by Oliver Latham, Charles River Associates International, London ********** You’ve been chief economist through a period of big developments in competition policy. We have got the rise of New Brandeisian thinking in the US, a more muscular approach to merger (...)

David Bosco, Ian Simmons, James Killick, Kenneth O’Rourke, Ombline Ancelin, Pascal Berghe, Pierre Régibeau, Stephen McIntyre Pay for delay : Les accords de report d’entrée dans le secteur pharmaceutique


Les auteurs de ce Tendances évoquent les décisions rendues aux Etats-Unis et en Europe relatives aux accords de report d’entrée dans le secteur pharmaceutique. Ces accords se sont multiplié ces dernières années et on pour objet de différer dans le temps l’arrivée d’un médicament générique qui (...)



Total des visites

Nombre de lectures par contribution

Nombre de contributions

Classement de l'auteur
En nombre de contributions
En nombre total de visites
En nombre moyen de visites
Envoyer un message